Compass Group PLC stock in focus after CFO Petros Parras buys shares as key dates loom

Compass Group PLC stock in focus after CFO Petros Parras buys shares as key dates loom

London, January 10, 2026, 08:01 GMT — Market closed

Compass Group PLC (CPG.L) chief financial officer Petros Parras bought 14,800 shares in the contract caterer at 23.838 pounds apiece on Friday, a regulatory filing showed. The stock ended down 0.47% at 2,345 pence, lagging a 0.8% rise in the FTSE 100. (TradingView)

The director dealing lands with the shares sitting nearer the bottom of their yearly range than the top, and investors looking for a clean catalyst to steady sentiment. It is a thin patch for company news, so even small signals can stick.

Compass in November forecast about 10% underlying operating profit growth and organic revenue growth — stripping out currency swings and acquisitions — around 7% for fiscal 2026, as easing inflation cuts the pace of price increases it passes on to clients. “We’re seeing inflation slowing down a fraction faster than what we thought last year,” Parras said on a post-results call. Aramark has described its 2026 outlook as encouraging, while France’s Sodexo has flagged slower growth after contract losses in the U.S. (Reuters)

Investors tend to watch PDMR dealings because they are one of the few real-time disclosures tied to top management. They can also mean little; purchases can be personal financial planning, and sales are often pre-set.

On the numbers, Compass carries a market value of about £39.9 billion and has traded between 2,249p and 2,853p over the past 12 months, with a price/earnings ratio around 24. Its dividend yield is about 2%, based on the last close.

But the buy does not settle the bigger question: whether volumes hold up if clients push harder on price or cut discretionary spend across offices, sports and travel sites. Lower inflation can also take some shine off reported revenue growth in catering, because many contracts pass costs through to customers.

Compass’s investor calendar shows the shares go ex-dividend on Jan. 15 and the group plans to publish a first-quarter trading update alongside its AGM on Feb. 5, with half-year results scheduled for May 11. Ex-dividend is the cut-off: buyers after that date miss the next payout — and the Feb. 5 update is likely the next test for the stock. (Compass Group)

Stock Market Today

  • Gilead Sciences priced for upside after 38.5% one-year gain, DCF signals undervaluation
    January 11, 2026, 11:55 AM EST. GILD traded near $121.10, up 0.6% in 30 days and 38.5% over the past year. The stock's longer-term returns-56.0% over three years and 131.7% over five-frame questions about risk and upside as investors reassess pipelines, approvals and competitive pressures in biopharma. A valuation check assigns Gilead Sciences a 5 out of 6 score, then three methods show divergent views. A two-stage free cash flow to equity model yields an intrinsic value around $274.50 per share, implying the stock is about 55.9% undervalued vs $121.10. The P/E stands at 18.53x, modest versus some biotech peers, underscoring how growth expectations and risk shape multiples. Overall, the model suggests meaningful upside from current levels.
Shell stock: buyback questions linger after Q4 chemicals warning, shares bounce back
Previous Story

Shell stock: buyback questions linger after Q4 chemicals warning, shares bounce back

Rio Tinto stock slides on Glencore merger talks as Feb 5 takeover deadline looms
Next Story

Rio Tinto stock slides on Glencore merger talks as Feb 5 takeover deadline looms

Go toTop